| Relevance of Course Objectives and Core Learning Outcomes(%) |
Teaching and Assessment Methods for Course Objectives |
| Course Objectives |
Competency Indicators |
Ratio(%) |
Teaching Methods |
Assessment Methods |
| Understand the medical background of some chronic inflammatory diseases (e.g. cancer), and the challenges in developing the therapeutics in treating these diseases. |
| 1.Possess professional knowledge in biomedical engineering |
| 3.Ability to write scientific papers and communicate research results effectively. |
| 4.Integration in interdisciplinary research and innovative research skills. |
|
|
|
| Attendance |
| Oral Presentation |
|
| Course Content and Homework/Schedule/Tests Schedule |
| Week |
Course Content |
| Week 1 |
Innate Immunity (I) |
| Week 2 |
Innate Immunity (II) |
| Week 3 |
Adaptive Immunity (I) |
| Week 4 |
Adaptive Immunity (II) |
| Week 5 |
Inflammation in Neurodegenerative diseases (I) |
| Week 6 |
Inflammation in Neurodegenerative diseases (II) |
| Week 7 |
Inflammatory drug targets in Neurodegenerative diseases (I) |
| Week 8 |
Inflammatory drug targets in Neurodegenerative diseases (II) |
| Week 9 |
Inflammation in Cancer (I) |
| Week 10 |
Inflammation in Cancer (II) |
| Week 11 |
Inflammatory drug targets in Cancer (I) |
| Week 12 |
Inflammatory drug targets in Cancer (II) |
| Week 13 |
Inflammation in Cardiovascular Diseases (I) |
| Week 14 |
Inflammation in Cardiovascular Diseases (II) |
| Week 15 |
Inflammatory drug targets in Cardiovascular Diseases (I) |
| Week 16 |
Inflammatory drug targets in Cardiovascular Diseases (II) |
| Week 17 |
Student Presentations |
| Week 18 |
Student Presentations |
|
| Evaluation |
Attendance (50%)
Oral Presentation (50% |
| Textbook & other References |
Hansson 2005 New England Journal of Medicine 352:1685-1695
Grivennikov et al. 2010 Cell 140: 883-899
Glass et al. 2010 Cell 140: 918-934
|
| Teaching Aids & Teacher's Website |
|
| Office Hours |
| Thursday 9-10am |
| Sustainable Development Goals, SDGs |
| | include experience courses：N |
|